NEW YORK (GenomeWeb News) – A collection of London research institutes and hospitals have banded together to launch an initiative to develop genetically tailored treatments for thousands of lung cancer patients, the Institute for Cancer Research said today.

The partners involved in the new London Lung Cancer Alliance plan to use tumor sequencing and genetic testing to personalize treatments for up to 3,000 lung cancer patients a year in London and in five other cities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.